Table 3.
The association between ZJU and Sarcopenia
| Characteristic | Model 1 | Model 2 | Model 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR1 | 95% CI1 | p-value | OR1 | 95% CI1 | p-value | OR1 | 95% CI1 | p-value | |
| ZJU index (quartile) | |||||||||
| Q1 | reference | reference | reference | ||||||
| Q2 | 3.32 | 2.23, 4.96 | < 0.001 | 2.77 | 1.84, 4.16 | < 0.001 | 2.73 | 1.82, 4.11 | < 0.001 |
| Q3 | 7.02 | 4.82, 10.24 | < 0.001 | 5.17 | 3.52, 7.61 | < 0.001 | 4.96 | 3.37, 7.32 | < 0.001 |
| Q4 | 15.90 | 11.04, 22.90 | < 0.001 | 13.08 | 9.00, 19.02 | < 0.001 | 12.40 | 8.46, 18.17 | < 0.001 |
| P for trend | < 0.001 | < 0.001 | < 0.001 | ||||||
1OR = Odds Ratio, CI = Confidence Interval
Model 1: no covariates were adjusted
Model 2: adjusted for Age, Gender, Race, Education attainment, Marital status, and PIR
Model 3: adjusted for Age, Gender, Race, Education attainment, Marital status, PIR, Hypertension, Diabetes, Cancer, Trouble sleeping, Current drinker, Current smoker, PA (min/week), Protein intake (g), Carbohydrate intake (g), and Fat intake (g)